Edition:
India

ICAD Inc (ICAD.OQ)

ICAD.OQ on NASDAQ Stock Exchange Capital Market

2.88USD
19 Sep 2018
Change (% chg)

-- (--)
Prev Close
$2.88
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
8,002
52-wk High
$4.89
52-wk Low
$2.81

Latest Key Developments (Source: Significant Developments)

Icad - Xoft Axxent Electronic Brachytherapy System Received Aerb Type Approval For Use In India
Wednesday, 29 Aug 2018 

Aug 29 (Reuters) - ICAD Inc ::ICAD INC - XOFT AXXENT ELECTRONIC BRACHYTHERAPY SYSTEM RECEIVED AERB TYPE APPROVAL FOR USE IN INDIA.  Full Article

iCAD Q2 GAAP Loss Per Share $0.06
Wednesday, 15 Aug 2018 

Aug 14 (Reuters) - ICAD Inc ::ICAD REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS.Q2 GAAP LOSS PER SHARE $0.06.Q2 REVENUE FELL 4 PERCENT TO $6.2 MILLION.QTRLY NON-GAAP ADJUSTED LOSS PER SHARE $0.06.  Full Article

iCad Reports Q1 GAAP Loss Per Share $0.20
Tuesday, 15 May 2018 

May 14 (Reuters) - ICAD Inc ::ICAD REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS.Q1 GAAP LOSS PER SHARE $0.20.Q1 REVENUE FELL 7 PERCENT TO $6.3 MILLION.  Full Article

iCAD Expects To Reduce About 18 Pct Of Workforce Across Skin Subscription Business
Saturday, 6 Jan 2018 

Jan 5 (Reuters) - Icad Inc ::ICAD INC SAYS CO EXPECTS TO REDUCE HEADCOUNT ACROSS SKIN SUBSCRIPTION BUSINESS BY ABOUT 21 EMPLOYEES OR 18% OF THE WORKFORCE- SEC FILING.ICAD INC SAYS ON JAN 4, CO ADOPTED A PLAN TO DISCONTINUE OFFERING RADIATION THERAPY PROFESSIONAL SERVICES TO PRACTICES.  Full Article

ICAD reports Q3 GAAP loss per share $0.42
Thursday, 9 Nov 2017 

Nov 8 (Reuters) - ICAD Inc ::ICAD reports third quarter 2017 financial results.Q3 GAAP loss per share $0.42.Q3 revenue rose 17 percent to $7.0 million.  Full Article

BRIEF-Icad Q4 Gaap Loss Per Share $0.26

* ICAD REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS